PTA Balloon Catheter Market Report 2025

The PTA balloon catheter market size has grown rapidly in recent years. It will grow from $2.33 billion in 2024 to $2.58 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to patient preference for non-surgical interventions, regulatory approvals and standards, healthcare infrastructure development, physician preference and expertise, rise in diabetes and obesity cases.

The PTA balloon catheter market size is expected to see rapid growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to rising cardiovascular disease cases, aging population dynamics, focus on minimally invasive procedures, increasing diabetes and obesity rates, healthcare infrastructure expansion. Major trends in the forecast period include enhanced training and education, shift to value-based healthcare, focus on safety and biocompatibility, robotics and navigation systems, patient-specific treatment.

The rising prevalence of cardiovascular disorders is anticipated to drive the growth of the PTA balloon catheter market in the coming years. Cardiovascular disorders encompass conditions that affect the heart or blood vessels, and an increase in these diseases necessitates advanced diagnostic and treatment options, such as PTA balloon catheters, thus boosting market demand. For example, in May 2023, a report by The Indiana Department of Health (IDOH) indicated that out of an estimated 250,000 central line-associated bloodstream infections (CLABSIs) occurring annually in U.S. hospitals, around 80,000 are reported in intensive care units (ICUs). Consequently, the growing prevalence of cardiovascular disorders is supporting the expansion of the PTA balloon catheter market.

The growing geriatric population is anticipated to drive the expansion of the PTA balloon catheter market in the coming years. The geriatric population, comprising individuals aged 65 and older, has unique healthcare needs related to aging. PTA balloon catheters play a vital role in managing cardiovascular conditions in elderly individuals, supporting vascular health and overall well-being. For example, in October 2022, the World Health Organization, a specialized health agency, reported that by 2030, 1 in 6 individuals globally will be aged 60 or older, with this figure projected to reach 2.1 billion by 2050. Thus, the growing geriatric population is fueling the growth of the PTA balloon catheter market.

Leading companies in the PTA balloon catheter market are prioritizing innovative products like infusion systems to improve patient outcomes and enhance procedural efficiency. Infusion systems are medical devices specifically designed for the intravenous administration of fluids, medications, or nutrients to patients. They provide precise control over dosage and flow rates, thereby improving treatment effectiveness and ensuring patient safety. For example, in April 2022, Terumo Corporation, a Japan-based medical device company, launched Terumo Medical Care Solutions (TMCS). This initiative represents a significant advancement in Terumo's commitment to positively impacting society through healthcare. By emphasizing quality time for both healthcare providers and patients, TMCS seeks to tackle contemporary challenges in medical care while enhancing the overall patient experience. This move not only underscores Terumo's century-long legacy in medical technology but also strategically positions the company for future growth in an increasingly complex healthcare landscape.

Major companies in the PTA balloon catheter market are strategically focusing on product launches, such as the PTA balloon catheter, to serve as a unique bridge between renal and vascular divisions. A notable example is Nipro Corporation, a Japan-based medical equipment manufacturing company. In March 2022, Nipro Corporation introduced the Cronus HP PTA balloon catheter, which offers robust performance at high pressures, graduated control angioplasty using a single balloon, and enhanced ease of entry across lesions to minimize balloon dog boning. These features provide an innovative edge, addressing procedural challenges and potentially improving overall efficacy, making it a valuable tool for vascular surgeons and interventionalists.

In December 2022, Boston Scientific Corporation, a US-based manufacturing company, acquired Acotec Scientific Holdings Ltd. for an undisclosed sum. This acquisition is intended to bolster Boston Scientific Corporation's product portfolio and broaden its market presence within the medical device sector. Acotec Scientific Holdings Ltd. is a China-based medical technology company that specializes in the development and manufacturing of innovative medical devices, particularly in the realm of interventional cardiology and related fields.

Major companies operating in the PTA balloon catheter market include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Lepu Medical, B. Braun Corporation, Terumo, Nipro Medical, Teleflex, Cook Medical, Biotronik, Merit Medical, Microport Scientific, Cardiovascular Systems, Well Lead Medical, Cardionovum, Surmodics, JOTEC, Creagh Medical, Natec Medical, TriReme Medical, Andratec, Acotec Scientific, Kaneka Corporation.

North America was the largest region in the PTA balloon catheter market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pta balloon catheter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pta balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A PTA balloon catheter is a medical procedure designed to widen a narrowed vessel opening using a small, flexible plastic tube or catheter with a 'balloon' at its end. This technique is utilized in minimally invasive catheterization procedures.

The primary types of PTA balloon catheters include polyurethane and nylon. Polyurethane is a material derived from plastic in various forms, with applications spanning coronary artery disease and peripheral vascular disease. These catheters find use in various healthcare settings, including hospitals, ambulatory surgical centers, and others.

The PTA balloon catheters market research report is one of a series of new reports that provides PTA balloon catheters market statistics, including the PTA balloon catheters industry’s global market size, regional shares, competitors with a PTA balloon catheters market share, detailed PTA balloon catheters market segments, market trends and opportunities, and any further data you may need to thrive in the PTA balloon catheters industry. This PTA balloon catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The PTA balloon catheter market consists of sales of non-compliant (high-pressure) balloons, semi-compliant (mid pressure), and compliant (elastomeric) balloons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.